What is Lexicon Pharmaceuticals's royalty income?

Lexicon Pharmaceuticals (LXRX) reported royalty income of $12K in Q1 2026.

What is the long-term trend for Lexicon Pharmaceuticals's royalty income?

Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's royalty income has grown at a -14.9% compound annual growth rate (CAGR), from $298K to $156K.

What does royalty income mean?

Revenue generated from licensing intellectual property, patents, or drug candidates to third parties. This represents a non-operating income stream that leverages the company's research and development assets without requiring direct commercialization efforts.

Lexicon Pharmaceuticals LXRX Royalty income

Royalty income at other companies

Lightwave Logic, Inc.LWLG

$50K—

Lexicon PharmaceuticalsLXRX

$12K—

Carter'sCRI

$4.53M-6.0%

Helix Energy Solutions GroupHLX

$1.69M+19.2%

Sarepta Therapeutics, Inc.SRPT

$4.18M+5.8%

PfizerPFE

$396M+28.6%

Segments

By segment

See full

Reportable Segment$12K—

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+262%

Enterprise value$976.73M+209%

P/S14.2×+5.4×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RoyaltyIncomeNonoperating.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's royalty income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's royalty income?: Lexicon Pharmaceuticals (LXRX) reported royalty income of $12K in Q1 2026.
What is the long-term trend for Lexicon Pharmaceuticals's royalty income?: Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's royalty income has grown at a -14.9% compound annual growth rate (CAGR), from $298K to $156K.
What does royalty income mean?: Revenue generated from licensing intellectual property, patents, or drug candidates to third parties. This represents a non-operating income stream that leverages the company's research and development assets without requiring direct commercialization efforts.